Coke’s sales fizzle as coronavirus keeps customers from convenience stores, movie theaters and activities

- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -

Coca-Cola Co. is seeing its sales squeezed by the coronavirus lockdown, with customers unable to grab a beverage at places like movie theaters, office soda machines or convenience stores as they head out for a day’s activity.

Coca-Cola KO, -2.47% has enjoyed the pantry-loading bump that many companies selling food and beverages for the home have experienced. The company reported an earnings and sales beat for the first quarter.

But April month-to-date volume trends have slumped 25% around the world, said James Quincey, Coca-Cola’s chief executive, who described the impact of the social distancing measures as “profound.”

See: Shake Shack says ‘confusing’ small business loan program needs to change to provide a lifeline to ailing restaurants

“The biggest impact has been a sharp decline in the important away-from-home portion of our business, which includes our eating and drinking channel as well as our on-the-go-oriented channels such as convenience retail,” he said, according to a FactSet transcript.

“While our exposure varies across markets, away-from-home broadly represents about half of our business given our strong share positions. In some markets, like the U.S., drive-thru operations and carryout offset some of the pressure, but most restaurants are operating on limited hours and are seeing overall trips decline sharply.”

To combat this, Coca-Cola is reconsidering certain promotions, innovation projects and other areas of the business to adjust to the new consumer behavior. The company is also focused on e-commerce, where the company is seeing more household necessities being delivered.

Read:Grocery prices are rising as eat-at-home demand soars during the coronavirus pandemic

Coca-Cola shares were down 2.6% on Tuesday, and have fallen 4.4% over the last year. The Dow Jones Industrial Average DJIA, -2.67% has fallen 13.3% over the past 12 months.

Coca-Cola’s revenue will suffer from shortcomings online, said Ryan Giannotto, director of research at GraniteShares, which offers the GraniteShares XOUT U.S. Large Cap ETF XOUT, -3.32%. GraniteShares excludes Coca-Cola for this reason as well as “lackluster management and poor capital reinvestment,” he said.

XOUT is down 10.5% for the year to date while the Dow Jones Industrial Average is down 19.3% for the period.

“The challenge ahead for Coca-Cola is that (so) much of its revenue is hard-linked to the physical economy (i.e. movie theaters, restaurants and workplaces) that its sales volumes have proven particularly vulnerable to the global shutdown,” Giannotto said.

“The 25% April volume contraction underscores this reality that companies without a realistic outlet to the digital economy will disproportionately struggle this quarter, and likely on a forward-looking basis.”

Coca-Cola remains a top pick for CFRA, however, despite that steep decline in April volume.

“With its 3.5% dividend yield and high single-digit long-term earnings per share growth goal, we view Coca-Cola as a stock capable of low double-digit total return potential and see little risk to Coca-Cola’s dividend, noting its streak of 58 years of dividend hikes and liquidity boost from a $5 billion long-term debt offering in March.”

CFRA rates Coca-Cola stock strong buy with a $55 price target, which it lowered from $60.

Originally Published on MarketWatch


Home of Science
Follow me

- Advertisement -




Top Ten Shows of the Next Decade

With the year ahead for the biggest new shows of the century approaching, the genre has its top ten hottest shows of the next...

Why Did Priyank Chopra Write Only Good Books?

Why Did Priyank Chopra Write Only Good Books?People like Priyank Chopra's books. They are not really that many, but they all seem to...

Priyank Chopra in ‘Dancing With Demons’ – A Star is Born

Priyank Chopra in 'Dancing With Demons' - A Star is BornHis films made him the star of India and a major player in...

Trump says he takes hydroxychloroquine to prevent coronavirus infection even though it’s an unproven treatment

KEY POINTS President Donald Trump said Monday that he has been taking anti-malaria drug hydroxychloroquine for over a week to prevent coronavirus infection even...

As Germany begins to open up, here’s a look at which European countries have relaxed their coronavirus restrictions

First in, first out. As European nations contracted coronavirus earlier than the U.S., they also are relaxing restrictions as the COVID-19 disease is spreading more...
Home of Science
Follow me